Skip to main content
Clinical Trials/NCT02121054
NCT02121054
Completed
Not Applicable

Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease

Young-Hak Kim, MD, PhD1 site in 1 country1,527 target enrollmentOctober 19, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
Young-Hak Kim, MD, PhD
Enrollment
1527
Locations
1
Primary Endpoint
Major adverse event
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.

Registry
clinicaltrials.gov
Start Date
October 19, 2013
End Date
October 29, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Young-Hak Kim, MD, PhD
Responsible Party
Sponsor Investigator
Principal Investigator

Young-Hak Kim, MD, PhD

MD, PhD

Asan Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients with coronary artery disease
  • Patients with peripheral artery disease

Exclusion Criteria

  • Renal dysfunction
  • Hepatic dysfunction
  • Major surgery planned within 1 year
  • Malignant tumor
  • History of gastrointestinal bleeding
  • low or high platelet count

Outcomes

Primary Outcomes

Major adverse event

Time Frame: 2 year

Major adverse event : overall mortality, cardiovascular mortality, target vessel revascularization

Secondary Outcomes

  • Biomarker(2 year)

Study Sites (1)

Loading locations...

Similar Trials